Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with inflammatory arthritis: concept and preliminary data

Oliver Hendricks*, Tonny Elmose Andersen, Afshin Ashouri Christiansen, Ellen Margrethe Hauge, Tina Ingrid Horsted, Anders Bo Bojesen, Mikkel Østergaard, Merete Lund Hetland, Niels Steen Krogh, Kirsten Kaya Roessler, Kim Hørslev-Petersen

*Kontaktforfatter

Publikation: Kapitel i bog/rapport/konference-proceedingKonferenceabstrakt i proceedingsForskningpeer review

OriginalsprogEngelsk
TitelAbstract book
Antal sider1
ForlagBio Events
Publikationsdato3. dec. 2023
Sider9
ArtikelnummerP-57
StatusUdgivet - 3. dec. 2023
BegivenhedMedical Cannabis 2023: The 4.th International Annual Congress on Controversies on Cannabis-Based Medicines - Frankfurt, Tyskland
Varighed: 4. dec. 20235. dec. 2023
Konferencens nummer: 4

Konference

KonferenceMedical Cannabis 2023
Nummer4
Land/OmrådeTyskland
ByFrankfurt
Periode04/12/202305/12/2023

Citationsformater